FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
FDA Press Announcements | Jul 24, 2018
Are you prone to feeling guilty? Then you're probably more trustworthy, study shows
Newswise | Jul 24, 2018
Link between diabetes and cancer risk firmly established
Healthline/Medical News Today | Jul 23, 2018
ADHD drugs do not improve cognition in healthy college students
Newswise | Jul 23, 2018
Tanning beds: A carcinogen at the gym
University of Connecticut Health News | Jul 23, 2018
Overcoming resistance to a standard chemotherapy drug
Emory's Woodruff Health Sciences Center News | Jul 23, 2018
Monkey studies reveal possible origin of human speech
Rockefeller University News | Jul 23, 2018
Discovery of kidney cancer driver could lead to new treatment strategy
Newswise | Jul 23, 2018